Australia markets close in 36 minutes

Firebrick Pharma Limited (FRE.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.2050+0.0050 (+2.50%)
As of 03:12PM AEDT. Market open.
Currency in AUD

Valuation measures4

Market cap (intra-day) 33.84M
Enterprise value 28.93M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.65k
Price/book (mrq)6.60
Enterprise value/revenue 7.02k
Enterprise value/EBITDA -7.64

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-50.00%
S&P500 52-week change 3-13.21%
52-week high 30.4950
52-week low 30.1850
50-day moving average 30.2102
200-day moving average 30.2625

Share statistics

Avg vol (3-month) 362.03k
Avg vol (10-day) 394.33k
Shares outstanding 5169.2M
Implied shares outstanding 6N/A
Float 890.8M
% held by insiders 173.92%
% held by institutions 11.12%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2022
Most-recent quarter (mrq)31 Dec 2022


Profit margin 0.00%
Operating margin (ttm)-483.95%

Management effectiveness

Return on assets (ttm)-63.18%
Return on equity (ttm)-110.67%

Income statement

Revenue (ttm)1.1M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)540.60%
Gross profit (ttm)1.08M
Net income avi to common (ttm)-5.39M
Diluted EPS (ttm)-0.0300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.91M
Total cash per share (mrq)0.03
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)10.50
Book value per share (mrq)0.03

Cash flow statement

Operating cash flow (ttm)-5.07M
Levered free cash flow (ttm)-3.07M